CGT Healthcare Partnerships
CGT Healthcare plays a crucial role in advancing cellular therapies and bringing treatments to patients more quickly and equitably. As a trusted partner to researchers, CGT Healthcare provides a range of services that support the development and production of cutting-edge cellular therapies. These services include process development, manufacturing, and logistics, which help to streamline the research process and bring therapies to market more quickly. In addition, CGT Healthcare partners with hospitals and other healthcare providers to help alleviate pain points and reduce the cost and complexity of logistics. By working closely with both researchers and healthcare providers, CGT Healthcare plays a critical role in making cellular therapies more accessible and effective for patients around the world.
Cell and Gene Therapies
Umbilical Cord Blood
Providing scientists with cancerous blood and tissue can improve treatment options and save lives.
Blood from pregnant women improves Non-invasive prenatal test (NIPT) screening.
Cell and Gene Therapies
Partnering with hospitals is a critical part of our mission at CGT Healthcare. We aim to make cell and gene therapies more accessible to patients around the world. By working directly with hospitals, we can help to streamline the therapy process, reducing the cost and complexity of logistics and ultimately making these treatments more affordable for patients.
Lab Testing and Diagnostics
CGT Healthcare provides COVID-19 testing for healthcare providers struggling to keep up with the overwhelming demand for rapid, reliable tests. We provide molecular RT-PCR and antibody testing in our rigorously validated, state-of-the-art labs. Our direct integration with your medical software systems ensures the quickest turnaround times and immediate access to available test results.
Umbilical Cord Blood Donation
There are more than 200 clinical trials worldwide investigating the use of cord blood stem cells in regenerative therapy. These developments depend on the innovative research conducted at academic institutions and within the biotech and pharmaceutical industries, using donor contributions of cord blood for research.
Highly skilled technicians at the CGT Healthcare Foundation are trained to maximize cord blood draws with every collection opportunity. The team works side-by-side with the hospital Labor and Delivery staff to ensure a positive experience.
Cancer Research Program
StemExpress Foundation has partnered with a vast network of healthcare providers around the globe, connecting biomedical researchers with compatible blood and tissue donors in an effort to advance cancer research. We understand the need for consistent, reproducible samples as well as global sourcing of rare disease-state donors. Our extensive donor database grants scientists access to these invaluable raw materials and give providers and patients the opportunity to take part in life-saving research.
Maternal Blood Program
Maternal blood testing is a safe and effective way of detecting chromosomal abnormalities during pregnancy. StemExpress Foundation has long supported the commercial development of Non-Invasive Prenatal Tests (NIPT). These tests are important to ensure expecting mothers obtain the correct information concerning their child’s health. Maternal blood samples from willing donors can provide researchers with the means to continue the development and advancement of NIPT screening. StemExpress can connect your patients with researchers who rely heavily on maternal blood donations. We offer onsite training to ensure that the collection process has little to no impact on your regular business and patient care.
Healthcare Operations Manager
Partner With Us